Old Web
English
Sign In
Acemap
>
authorDetail
>
Kalai Mangai Muthukumarasamy
Kalai Mangai Muthukumarasamy
University of Copenhagen
Pharmacology
Atrial fibrillation
Medicine
SK channel
Dofetilide
3
Papers
16
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Mechanisms of Action of the KCa2-Negative Modulator AP30663, a Novel Compound in Development for Treatment of Atrial Fibrillation in Man.
2020
Frontiers in Pharmacology
Bo Hjorth Bentzen
Sofia Hammami Bomholtz
Rafel Simó-Vicens
Lasse Folkersen
Lea Abildgaard
Tobias Speerschneider
Kalai Mangai Muthukumarasamy
Nils Edvardsson
Ulrik Svane Sørensen
Morten Grunnet
Jonas Goldin Diness
Show All
Source
Cite
Save
Citations (3)
The KCa2 Channel Inhibitor AP14145, But Not Dofetilide or Ondansetron, Provides Functional Atrial Selectivity in Guinea Pig Hearts
2019
Frontiers in Pharmacology
Jeppe Egedal Kirchhoff
Mark A. Skarsfeldt
Kalai Mangai Muthukumarasamy
Rafel Simó-Vicens
Sofia Hammami Bomholtz
Lea Abildgaard
Thomas Jespersen
Ulrik Svane Sørensen
Morten Grunnet
Bo Hjorth Bentzen
Jonas Goldin Diness
Show All
Source
Cite
Save
Citations (7)
Impact of arrhythmogenic calmodulin variants on small conductance Ca 2+ ‐activated K + (SK3) channels
2019
Physiological Reports
Arnela Saljic
Kalai Mangai Muthukumarasamy
Jonas M. la Cour
Kim Boddum
Morten Grunnet
Martin W. Berchtold
Thomas Jespersen
Show All
Source
Cite
Save
Citations (6)
1